Novel Management of Masticatory Myositis in Three Dogs with a Selective Janus Kinase (JAK-1) Inhibitor.

Masticatory myositis (MM) is an inflammatory myopathy reported in dogs and is characterized by inflammation of the masticatory muscles (temporalis, masseter, and pterygoid muscles). Immunosuppressive therapy is the current recommended treatment for MM and may involve glucocorticoids, cyclosporine, azathioprine, mycophenolate mofetil, leflunomide, or a combination of these treatments that are slowly tapered to the lowest effective dose. However, side effects from multimodal medical therapy and complications associated with MM relapses have been reported. The purpose of this case series was to report oclacitinib as a treatment alternative to traditional medical management of MM. The intent of this alternative is to manage side effects from glucocorticoid use. Oclacitinib (1mg/kg per os q12h) was used solely for treatment of MM in three dogs. The dogs were followed up to >6 months after oclacitinib administration. An increase in oral range of motion, as determined by gape angle, was noted in all three dogs. However, a corresponding drop in antibody titers (2M fiber) did not occur. All dogs showed improvement in overall clinical management of MM, side effects from glucocorticoids, and clinical signs related to chronic prednisone use. Larger controlled trials with consistent measurements (interincisal distance, gape angle) and 2M fiber antibody titers are indicated to further assess validation of oclacitinib treatment of MM. The clinical outcome of all dogs was considered successful.

Application of a maxillary transfacial approach to the caudal oral cavity and orbitozygomaticomaxillary complex in dogs.

Surgical access and visualization for excision of large pathologic lesions of the orbitozygomaticomaxillary complex (OZMC) and caudal oral cavity can be a challenge in veterinary oromaxillofacial surgery and may limit one's ability to perform such procedures. Combined intra- and extra-oral approaches as well as commissurotomy have been advocated in the past. However, each of these approaches present unique limitations specific to each approach. A transfacial approach that ameliorated these limitations could be advantageous. In this descriptive cohort study, we investigate the application and outcomes of a maxillary transfacial approach to the OZMC and caudal oral cavity in six client-owned dogs. The approach is based on the Weber-Ferguson approach for human applications and provided excellent exposure of the intended region in all six patients. We contend the maxillary transfacial approach provides some advantages to the more conventional combined intra-oral/extra-oral approach or commissurotomy for excision of large pathologic lesions of the OZMC and caudal oral cavity.

Corrigendum: Analysis of the approach angle to medial orbitotomy that avoids accidental neurotrauma in the mesaticephalic dog skull utilizing 3D computer models and virtual surgical planning.

[This corrects the article DOI: 10.3389/fvets.2023.1185454.].

Analysis of the approach angle to medial orbitotomy that avoids accidental neurotrauma in the mesaticephalic dog skull utilizing 3D computer models and virtual surgical planning.

This study was conducted to determine an approach angle to medial orbitotomy that avoids accidental neurotrauma in mesaticephalic dogs. Medical records of dogs with mesaticephalic skulls that were presented to the veterinary medical teaching hospital for head computed tomography (CT) between September 2021 and February 2022 were reviewed. Descriptive data were queried, and CT findings were analyzed. Dogs greater than 20 kg and possessing a disease-free orbitozygomaticomaxillary complex (OZMC) on at least one side of the skull were included in this study. Digital imaging and communications in medicine (DICOM) files of head CT studies were imported into medical modeling software, and the safe approach angle for medial orbitotomy was determined using three-dimensional (3D) computer models and virtual surgical planning (VSP) principles. Angles were measured along the ventral orbital crest (VOC) from the rostral cranial fossa (RCF) to the rostral alar foramen (RAF). The safe approach angle at four points from rostral to caudal along the VOC was measured. The results at each location were reported as mean, median, 95% CI, interquartile ranges, and distribution. The results were statistically different at each location and generally increased from rostral to caudal. The variances between subjects and the differences between locations were large enough to suggest a standard safe approach angle in mesaticephalic dogs cannot be determined and should be measured for each patient. A standardized approach angle to medial orbitotomy is not possible in the mesaticephalic dog. Computer modeling and VSP principles should be implemented as part of the surgical planning process to accurately measure the safe approach angle along the VOC.